静脉水合疗法市场－全球产业规模、份额、趋势、机会及预测（按服务、组件、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球静脉水合疗法市场价值为 25.1 亿美元，预计到 2030 年将达到 39.4 亿美元，复合年增长率为 7.80%。这种增长主要归因于慢性病发病率的增加、手术量的增加以及全球静脉注射药物批准数量的增加。静脉注射治疗诊所的扩张也增强了公司的地理影响力，从而提高了市场渗透率。此外，静脉注射疗法的有效性和快速反应时间使其成为治疗营养不良和提供必需营养素的理想解决方案，特别是对于无法口服食物的患者。人口老化对静脉营养支持的需求不断增加，进一步推动了市场扩张。一个值得注意的例子是 Sameday Health 于 2022 年 7 月推出的 Inner Beauty IV 滴注，该产品强调健康和美学益处，例如改善皮肤、指甲和头髮健康，凸显了消费者对预防和生活方式医疗保健的日益关注。

关键市场驱动因素

慢性病和脱水相关疾病盛行率上升

主要市场挑战

监管和安全问题

主要市场趋势

技术进步与服务创新

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球静脉水合疗法市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按服务（免疫增强剂、能量增强剂、皮肤护理、其他）
  • 按组成部分（紧急医疗保健、常规医疗保健）
  • 按最终使用者（医院和诊所、健康中心和水疗中心、家庭医疗保健、其他）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
• 按服务
• 按组件
• 按最终用户
• 按地区

第六章：北美IV水合疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲IV水合疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太静脉水合疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲IV水合疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲 IV水合疗法市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球静脉水合疗法市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global IV Hydration Therapy Market was valued at USD 2.51 billion in 2024 and is projected to reach USD 3.94 billion by 2030, growing at a CAGR of 7.80%. This growth is primarily attributed to the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals worldwide. The expansion of IV therapy clinics is also enhancing companies' geographic presence, thereby boosting market penetration. Additionally, the effectiveness and quick response time of IV therapy make it an ideal solution for treating malnutrition and delivering essential nutrients, especially for patients unable to consume food orally. The aging population, with a heightened need for intravenous nutritional support, is further fueling market expansion. A notable example includes Sameday Health's launch of the Inner Beauty IV drip in July 2022, which emphasizes wellness and aesthetic benefits such as improved skin, nails, and hair health, highlighting the increasing consumer focus on preventive and lifestyle healthcare.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Dehydration-Related Conditions

The growing global burden of chronic illnesses and dehydration-related issues significantly drives the demand for IV hydration therapy. Conditions like diabetes, kidney disease, and digestive disorders often result in fluid imbalances, making intravenous hydration essential for effective treatment. According to the World Health Organization, chronic diseases account for 71% of all global deaths, indicating a broad base of potential IV therapy patients. Dehydration is particularly prevalent among elderly individuals, athletes, and those under stress. The CDC reports that older adults are especially susceptible due to reduced thirst sensitivity and coexisting health conditions, which reinforces the importance of accessible and reliable hydration solutions through IV therapy.

Key Market Challenges

Regulatory and Safety Concerns

IV hydration therapy faces notable regulatory and safety obstacles that could impede market growth. A lack of consistent regulatory frameworks across different regions raises concerns about the quality and professionalism of services offered. In some areas, IV treatments are administered by staff lacking proper medical training, posing risks such as infections, vein inflammation, or electrolyte imbalances. Furthermore, the U.S. FDA has not approved IV hydration therapy for general wellness applications, underlining the need for more comprehensive clinical research to establish safety and efficacy. Addressing these challenges requires the implementation of standardized protocols and oversight to maintain patient safety and public trust.

Key Market Trends

Technological Advancements and Service Innovations

Innovations in technology are reshaping the IV hydration therapy market by making treatments more accessible and patient-centric. Portable infusion systems and integration with telemedicine platforms have enabled home-based treatments, broadening the reach of IV therapy. Additionally, clinics are increasingly offering personalized IV solutions tailored to specific wellness goals, such as immune support, detoxification, and anti-aging. This trend toward customization reflects the rising consumer demand for individualized healthcare experiences, helping drive adoption across various patient segments.

Key Market Players

• Core IV Therapy, LLC
• Cryojuvenate UK
• B. Braun SE
• Pfizer, Inc.
• JW Life Science
• Amanta Healthcare
• Vifor Pharma Management Ltd
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• ICU Medical, Inc.

Report Scope:

In this report, the Global IV Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

• Immune Booster
• Energy Booster
• Skin Care
• Others

IV Hydration Therapy Market, By Component:

• Emergency Healthcare
• Routine Healthcare

IV Hydration Therapy Market, By End User:

• Hospitals & Clinics
• Wellness Centers & Spa
• Home Healthcare
• Others

IV Hydration Therapy Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global IV Hydration Therapy Market.

Available Customizations:

Global IV Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IV Hydration Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 5.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Service
• 5.3.2 By Component
• 5.3.3 By End Users
• 5.3.4 By Region

6. North America IV Hydration Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 6.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 6.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States IV Hydration Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada IV Hydration Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico IV Hydration Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe IV Hydration Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 7.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 7.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France IV Hydration Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany IV Hydration Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom IV Hydration Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy IV Hydration Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain IV Hydration Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia-Pacific IV Hydration Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 8.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 8.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China IV Hydration Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India IV Hydration Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan IV Hydration Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea IV Hydration Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia IV Hydration Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. South America IV Hydration Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 9.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 9.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil IV Hydration Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina IV Hydration Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia IV Hydration Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. Middle East and Africa IV Hydration Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Others)
  • 10.2.2. By Component (Emergency Healthcare, Routine Healthcare)
  • 10.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa IV Hydration Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE IV Hydration Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global IV Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Core IV Therapy, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Cryojuvenate UK
• 15.3. B. Braun SE
• 15.4. Pfizer, Inc.
• 15.5. JW Life Science
• 15.6. Amanta Healthcare
• 15.7. Vifor Pharma Management Ltd
• 15.8. Otsuka Pharmaceutical Co., Ltd.
• 15.9. Baxter
• 15.10. ICU Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer